Article
The complex development of psoralen-interstrand crosslink resistance in <i>Escherichia coli</i> requires AcrR inactivation, retention of a <i>marbox</i> sequence, and one of three MarA, SoxS, or Rob global regulators
2024-12-07
Abstract excerpt
Crosslinking agents, such as psoralen and UVA radiation, can be effectively used as antimicrobials and for treating several dysplastic conditions in humans, including some cancers. Yet, both cancer cells and bacteria can become resistant to these compounds, making it important to understand how resistance develops. Recently, several mutants were isolated that developed high-levels of resistance to these compounds...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 97bc640c-50e2-515a-8ad9-a0ab03c01356
- DOI
- 10.1101/2024.12.03.626702
